Fundamental Structures and Behaviors of Proteins

Aggregation of Therapeutic Proteins

Volumn , Issue , 2010, Pages 1-61

  Laurence, Jennifer S ^a   Middaugh, Russell C ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Chemical alteration influences on aggregation; Ideal gas law, as limiting law tool describing protein folding; Protein aggregation a problem limiting efficacy and shelf life of protein therapeutics and pathology onset

Indexed keywords

EID: 79955581681     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470769829.ch1     Document Type: Chapter

References (208)

1. Chiti F, Dobson CM. 2009. Amyloid formation by globular proteins under native conditions. Nature Chem Biol 5 (1):15-22.
2. Dobson CM, Karplus M. 1999. The fundamentals of protein folding: Bringing together theory and experiment. Trends Biochem Sci 9: 92-101.
3. Maas C, Hermeling S, Bouma B, Jiskoot W, Gebbink M. 2007. A role for protein misfolding in immunogenicity of biopharmaceuticals. J Biol Chem 282: 2229-2236.
4. Kahn SE, Andrikopoulos S, Verchere CB. 1999. Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48: 241-253.
5. Cromwell MEM, Hilario E, Jacobson F. 2006. Protein aggregation and bioprocessing. AAPS J 8 (3): E572-E579.
6. Rosenberg AS. 2006. Effects of protein aggregates: An immunologic perspective. AAPS J 8 (3): E501-E507.
7. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. 2002. Molecular Biology of the Cell, 4th edition. New York: Garland Science.
8. Hartl FU, Hayer-Hartl M. 2002. Molecular chaperones in the cytosol: From nascent chain to folded protein. Science 295: 1852-1858.
9. Meredith SC. 2005. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Ann N Y Acad Sci 1066: 181-221.
10. Bagola K, Sommer T. 2008. Protein quality control: On IPODs and other JUNQ. Curr Biol 18: R1019-R1021.
11. Kaganovich D, Kopito R, Frydman J. 2008. Misfolded proteins partition between two distinct quality control compartments. Nature 454: 1088-1095.
12. Dinner AR, Karplus M. 1999. Is protein unfolding the reverse of protien folding? A lattice simulation analysis. J Mol Biol 292 (2): 403-419.
13. Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK. 2000. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif 18: 182-192.
14. Azakami H, Mukai A, Kato A. 2005. Role of amyloid type cross-ß-structure in the formation of soluble aggregate and gel in heat-induced ovalbumin. J Agric Food Chem 53: 1254-1257.
15. Sunde M, Blake C. 1997. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50: 123-155.
16. Curtis-Fisk J, Spencer DS, Weliky DP. 2008. Native conformation at specific residues in recombinant inclusion body protein in whole cells determined with sold-state NMR spectroscopy. J Am Chem Soc 130 (38): 12568-12569.
17. Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, Agard DA, Prusiner SB. 2002. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 99 (6): 3563-3568.
18. Antzutkin ON. 2000. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of ß-sheets in Alzheimer's ß-amyloid fibrils. Proc Natl Acad Sci USA 97 (24): 13045-13050.
19. Petkova AT, Leapman RD, Guo Z, Yau W-M, Mattson MP, Tycko R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's ß-amyloid fibrils. Science 307: 262-265.
20. Paravastu NK, Leapman RD, Yau W-M, Tycko R. 2008. Molecular structural basis for polymorphism in Alzheimer's ß-amyloid fibrils. Proc Natl Acad Sci USA 105: 18349-18354.
21. Hou L, Zagorski MG. 2004. Sorting out and driving forces for parallel and antiparallel alignment in the A ß peptide fibril structure. Biophys J 86: 1-2.
22. Dobson CM. 2006. The generic nature of protein folding and misfolding. In Uversky VN, Fink AL, eds., Protein Misfolding, Aggregation, and Conformational Diseases, Part A: Protein Aggregation and Conformational Diseases. New York: Springer, pp. 21-41.
23. Kayed R, Head E, Sarsoza S, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG. 2007. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neuordegener 2: 18.
24. Jayasinghe SA, Langen R. 2004. Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Biol Chem 279 (46): 48420-48425.
25. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. 2005. Structure of the cross-ß spine of amyloid-like fibrils. Nature 435 (9): 773-778.
26. Wiltzius JJW, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, Eisenberg D. 2008. Atomic structure of the cross-ß spine of islet amyloid poplypeptide amylin. Protein Sci 17: 1467-1474.
27. Luca S, Yau W-M, Leapman RD, Tycko R. 2007. Peptide conformation and supramolecular organization in amylin fibrils: Constraints from SOLID-State NMR. Biochemistry 46 (47): 13505-13522.
28. Sumner Makin O, Serpell LC. 2004. Structural characterisation of islet amyloid polypeptide fibrils. J Mol Biol 335: 1279-1288.
29. Kajava A, Aebi U, Steven A. 2005. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J Mol Biol 348 (2): 247-252.
30. Uversky VN, Fernandez A, Fink AL. 2006. Structural and conformational prerequisites of amyloidogenesis. In Uversky VN, Fink AL, eds., Protein Misfolding, Aggregation, and Conformational Diseases, Part A: Protein Aggregation and Conformational Diseases. New York: Springer, pp. 1-20.
31. Plakoutsi G, Bemporad F, Calamai M, Taddei N, Dobson CM, Chiti F.Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol 351 (4): 910-922
32. Glabe CG, Kayed R. 2006. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66 (Suppl. 1): S74-S78.
33. Wei G, Mousseau N, Derreumaux P. 2007. Computational simulations of the early steps of protein aggregation. Prion 1 (1): 3-8.
34. Anfinsen CB. 1973. Principles that govern the folding of protein chains. Science 181 (4096): 223-230.
35. Dill KA, Ozkan SB, Shell MS, Weikl TR. 2008. The protein folding problem. Annu Rev Biophys 37: 289-316.
36. Dobson CM. 2003. Protein folding and misfolding. Nature 426: 884-890.
37. Jahn TR, Radford SE. 2008. Folding versus aggregation: Polypeptide conformations on competing pathways. Arch Biochem Biophys 469: 100-117.
38. Dill KA, Chan HS. 1997. From Levinthal to pathways to funnels. Nature Struct Biol 4 (1): 10-19.
39. Dill KA, Fiebig KM, Chan HS. 1993. Cooperativity in protein-folding kinetics. Proc Natl Acad Sci USA 90: 1942-1946.
40. Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 20 (9): 1325-1336.
41. Dill KA. 1990. Dominant forces in protein folding. Biochemistry 29 (31): 7133-7155
42. Kim PS, Baldwin RL. 1990. Intermediates in the folding reactions of small proteins. Annu Rev Biochem 59: 631-660.
43. Rumbley J, Hoang L, Mayne L, Englander SW. 2002. An amino acid code for protein folding. Proc Natl Acad Sci USA 98 (1): 105-112.
44. Fan H, Vitharana SN, Chen T, O'Keefe D, Middaugh CR. 2007. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20. Mol Pharm 4 (2): 232-240.
45. Thirumangaluthu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. 2006. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci 95: 1480-1497.
46. Zhang Y, Roy S, Jones LS, Krishnan S, Kerwin BA, Chang BS, Manning MC, Randolph TW, Carpenter JF. 2004. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1-receptor antagonist in aqueous solution. J Pharm Sci 93: 3076-3089.
47. Dill KA, Alonso DOV, Hutchinson K. 1989. Thermal stabilities of globular proteins. Biochemistry 28: 5439-5449.
48. Dwyer JJ, Gittis AG, Karp DA, Lattman EE, Spencer DS, Stites WE, Garcia-Moreno B. 2000. High apparent dielectic constants in the interior of a protein reflect water penetration. Biophys J 79: 1610-1620.
49. Available at http://www.greenfluids.org/SubcriticalWater.htm (accessed January 2009). Available at
50. Gallivan JP, Dougherty DA. 1999. Cation-p interactions in structural biology. Proc Natl Acad Sci USA 96 (17): 9459-9464.
51. McGaughey GB, Gagnes M, Rappe AK. 1998. p-Stacking interactions: Alive and well in proteins. J Biol Chem 273 (25): 15458-15463.
52. Zhou Y, Linhananta A. 2002. Thermodynamics of an all-atom off-lattice model of the fragment B of staphylococcal protein A. J Phys Chem B 106 (6): 1481-1485.
53. Gazit E. 2002. A possible role for p-stacking in the self-assembly of amyloid fibrils. FASEB J 16: 77-83.
54. Tartaglia GG, Cavalli A, Pellarin R, Caflisch A. 2004. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci 13: 1939-1941.
55. Flocco MM, Mowbray SL. 1994. Planar stacking interactions of arginine and aromatic side-chains in proteins. J Mol Biol 235: 709-717.
56. Burley SK, Petsko GA. 1986. Amino-aromatic interactions in proteins. FEBS 203 (2): 139-143.
57. Wang S, Stauffacher CV, Van Etten RL. 2000. Structural and mechanistic basis for the activation of a low molecular weight protein tyrosine phosphatase by adenine. Biochemistry 39: 1234-1242.
58. Tishmack PA, Bashford D, Harms E, Van Etten RL. 1997. Use of 1H NMR spectroscopy and computer simulations to analyze pKa changes in a protein tyrosine phosphatase: Experimental and theoretical determination of electrostatic properties in a small protein. Biochemistry 36: 11984-11994.
59. Langer T, Lu C, Echols H, Flanagan J, Hayer-Hartl MK, Hartl FU. 1992. Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature 356: 683-689.
60. Marti DN, Bosshard HR. 2003. Electrostatic interactions in leucine zippers-Thermodynamic analysis of the contributions of Glu and His residues and the effect of mutating salt bridges. J Mol Biol 330: 621-637.
61. Kumar S, Nussinov R. 2002. Relationship between ion pair geometries and electrostatic strengths in proteins. Biophys J 83: 1595-1612.
62. Richardson JS, Richardson DC. 2002. Natural ß-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 99 (5): 2754-2759.
63. Chiti F. 2006. Relative importance of hydrophobicity, net charge, and secondary structure propensities in protein aggregation. In Uversky VN, Fink AL, eds., Protein Misfolding, Aggregation, and Conformational Diseases, Part A: Protein Aggregation and Conformational Diseases. New York: Springer, pp. 43-59.
64. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski M. 2001. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nature Struct Biol 8 (4): 316-320.
65. Wang W, Hecht MH. 2002. Rationally designed mutations convert de novo amyloid-like fibrils into monomeric ß-sheet proteins. Proc Natl Acad Sci USA 99 (5): 2760-2765.
66. Eisenberg D. 2003. The discovery of the a-helix and ß-sheet, the principal structural features of proteins. Proc Natl Acad Sci USA 100 (20): 11207-11210.
67. Pauling LN. 1960. The Nature of the Chemical Bond and the Structure of Molecules and Crystals: An Introduction to Modern Structural Chemistry, 3rd edition. Ithaca, New York: Cornell University Press.
68. Ramachandran GN, Ramakrishnan C, Sasisekharan V. 1963. Stereochemistry of polypeptide chain configurations. J Mol Biol 7: 95-99.
69. Shortle D. 2002. Composites of local structure propensities: Evidence for local encoding of lang-rang structure. Protein Sci 11: 18-26.
70. Avbelj F, Baldwin RL. 2002. Role of backbone solvation in determining thermodynamic ß propensities of the amino acids. Proc Natl Acad Sci USA 99 (3): 1309-1313.
71. Street AG, Mayo SL. 1999. Intrinsic ß-sheet propensities result from van der Waals interactions between side chains and the local backbone. Proc Natl Acad Sci USA 96: 9074-9076.
72. Alexandrescu AT, Kammerer RA. 2003. Structure and disorder in the ribonuclease S-peptide probed by NMR residual dipolar couplings. Protein Sci 12 (10): 2132-2140.
73. Feng L, Lee H-S, Prestegard JH. 2007. NMR resonance assignments for sparsely 15N labeled proteins. J Biomol NMR 38 (3): 213-219.
74. Buck M. 1998. Trifluoroethanol and colleagues: Cosolvents come of age. Recent studies with peptides and proteins. Q Rev Biophys 31 (3): 297-355.
75. Amani M, Yousefi R, Moosavi-Movahedi AA, Pintus F, Mura A, Floris G, Kurganov BI, Saboury AA. 2008. Structural changes and aggregation process of Cu/containing amine oxidase in the presence of 2,2,2 '-trifluoroethanol. Protein Pept Lett 15 (5): 521-527.
76. Bieler S, Soto C. 2004. ß-sheet breakers for Alzheimer's disease therapy. Curr Drug Targets 5: 553-558.
77. Chou PY, Fasman GD. 1978. Empirical predictions of protein conformation. Annu Rev Biochem 47: 251-276.
78. Penkett CJ, Redfield C, Dodd I, Hubbard J, McBay DL, Mossakowska DE, Smith RAG, Dobson CM, Smith LJ. 1997. NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding protein. J Mol Biol 274: 152-159.
79. Shen Y, Bax A. 2007. Protein backbone chemical shifts predicted from searching a database for torsion angle and sequence homology J Biomol NMR 38: 289-302.
80. Wishart D, Sykes B. 1994. The 13C chemical-shift index: A simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biolmol NMR 4: 171-180.
81. Creamer TP, Rose GD. 1992. Side chain entropy opposes alpha-helix formation but rationalizes experimentally-determined helix-forming propensities. Proc Natl Acad Sci USA 89: 5937-5941.
82. Creamer TP, Rose GD. 1994. Alpha-helix-forming propensities in peptides and proteins. Proteins 19: 85-97.
83. Glyakina AV, Garbuzynskiy SO, Lobanov MY, Galzitskaya OV. 2007. Different packing of external residues can explain differences in the thermostability of proteins from thermophilic and mesophilic organisms. Bioinformatics 23: 2231-2238
84. Dominy BN, Minoux H, Brooks CLI. 2004. An electrostatic basis for the stability of thermophilic proteins. Proteins 57: 128-141.
85. Takano K, Tsuchimori K, Yamagata Y, Yutani K. 2000. Contribution of salt bridges near the surface of a protein to the conformational stability. Biochemistry 39: 12375-12381.
86. Lindman S, Xue W-F, Szczepankiewicz O, Bauer MC, Nilsson H, Linse S. 2006. Salting the charged surface: pH and salt dependence of protein G B1 stability. Biophys J 90: 2911-2921.
87. Stigter D, Alonso DOV, Dill KA. 1991. Protein stability: Electrostatics and compact denatured states. Proc Natl Acad Sci USA 88: 4176-4180.
88. Lindman S, Linse S, Mulder FAA, Andre I. 2007. pKa values for side-chain caroxyl groups of a PGB1 variant explain salt and pH-dependent stability. Biophys J 92: 257-266.
89. Spek EJ, Bui AH, Lu M, Kallenbach NR. 1998. Surface salt bridges stabilize the GCN4 leucine zipper. Protein Sci 7: 2431-2437.
90. Strop P, Mayo SL. 2000. Contribution of surface salt bridges to protein stability. Biochemistry 39: 1251-1255.
91. Sharma S, Ding F, Dokholyan NV. 2008. Probing protein aggregation using simplified models and discrete dynamics. Front Biosci 13: 4795-4808.
92. Lodi PJ, Garrett DS, Kuszewski J, Tsang ML, Weatherbee JA, Leonard WJ, Gronenborn AM, Clore GM. 1994. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. Science 263: 1762-1767.
93. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. 2002. A structural model for Alzheimer's ß-amyloid fibrils based on experimental constraints from solid state NMR. Science 99: 6742-16747.
94. Mothana B, Roy S, Rauk A. 2009. Molecular dynamics study of the interaction of A ß (13-23) with ß-sheet inhibitors. ARKIVOC v: 116-134.
95. Klimov DK, Newfield D, Thirumalai D. 2002. Simulations of ß-hairpin folding confined to spherical pores using distributed computing. Proc Natl Acad Sci USA 99 (12): 8019-8024.
96. Bellesia G, Shea J-E. 2007. Self-assembly of ß-sheet forming peptides into chiral fibrillar aggregates. J Chem Phys 126: 245104-245111
97. Thurlkill RL, Grimsley GR, Scholtz JM, Pace CN. 2006. Hydrogen bonding markedly reduces the pK of buried carboxyl groups in proteins. J Mol Biol 362: 594-604.
98. Forsyth WR, Antosiewicz JM, Robertson AD. 2002. Empirical relationships between protein structure and carboxyl pKa values in proteins. Proteins 48: 388-403.
99. Kawamura S, Tanaka I, Yamasaki N, Kimura M. 1997. Contribution of a salt bridge to the thermostability of DNA binding protein HU from Bacillus stearothermophilus determined by site-directed mutagenesis. J Biochem 121 (3): 448-455.
100. Podust LM, Krezel AM, Kim Y. 2001. Crystal structure of the CCAAT box/ enhancer-binding protein. J Biol Chem 276: 505-513.
101. Carl N, Konc J, Janezic D. 2008. Protein surface conservation in binding sites. J Chem Inf Model 48: 1279-1286.
102. Jones S, Thornton JM. 1996. Principles of protein-protein interactions. Proc Natl Acad Sci USA 93: 13-20.
103. Matsuo H, Shirakawa M, Kyogoku Y. 1995. Three-dimensional dimer structure of the Λ-Cro repressor in solution as determined by heteronuclear multidimensional NMR. J Mol Biol 254 (4): 668-680.
104. Fermi G, Perutz MF, Shaanan B, Fourme R. 1984. The crystal structure of human deoxyhaemoglobin at 1.74 A resolution. J Mol Biol 175: 159.
105. Jeong DG, Kim SJ, Kim JH, Son JH, Park MR, Lim SM, Yoon TS, Ryu SE. 2005. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms. J Mol Biol 345: 401-413.
106. Pal SK, Peon J, Zewail AH. 2002. Biological water at the protein surface: Dynamical solvation probed directly with femtosecond resolution. Proc Natl Acad Sci USA 99 (4): 1763-1768.
107. Zhang L, Wang L, Kao Y-T, Qiu W, Yang Y, Okobiah O, Zhong D. 2007. Mapping hydration dynamics around a protein surface. Proc Natl Acad Sci USA 104 (47): 18461-18466.
108. Friedman R, Nachliel E, Gutman M. 2005. Molecular dynamics of a protein surface: Ion-residues interactions. Biophys J 89: 768-781.
109. Baldwin RL. 1996. How Hofmeister ion interactions affect protein stability. Biophys J 71: 2056-2063.
110. Timasheff SN. 2002. Protein hydration, thermodynamic binding, and preferential hydration. Biochemistry 41 (46): 13473-13482.
111. McLaurin J, Franklin T, Zhang X, Deng J, Fraser PE. 1999. Interactions of Alzheimer amyloid peptides with glycosaminoglycans. Effects on fibril nucleation and growth. Eur J Biochem 266: 1101-1110.
112. Fan H, Zhang M, Middaugh CR. 2007. Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1. J Pharm Sci 96 (6): 1490-1503.
113. Kamerzell TJ, Joshi SB, McClean D, Peplinkskie L, Toney K, Papac D, Li M, Middaugh CR. 2007. Parathyroid hormone is a heparin/polyanion binding protein; binding energetics and structure modification. Protein Sci 16 (6): 193-203.
114. Kamerzell TJ, Unruh JR, Johnson CK, Middaugh CR. 2006. Conformational flexibility, hydration and state parameter fluctuations of fibroblast growth factor-10: Effects of ligand binding. Biochemistry 45: 15288-15300.
115. Salamat-Miller N, Feng J, Seidel CW, Assenov Y, Albrecht M, Middaugh CR. A network-based analysis of polyanion-binding proteins utilizing human protein arrays. J Biol Chem 282 (14): 10153-10163.
116. Vendruscolo M, Paci E, Karplus M, Dobson CM. 2003. Structures and relative free energies of partially folded states of proteins. Proc Natl Acad Sci USA 100 (25): 14817-14821.
117. Margittai M, Langen R. 2006. Side chain-dependent stacking modulates tau filament structure. J Biol Chem 281 (49): 37820-37827.
118. Pain RH. 2000. Mechanisms of Protein Folding, 2nd edition. New York: Oxford University Press.
119. Fersht A. 1998. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding. London: W. H. Freeman Company.
120. Griffith JS. 1967. Self-replication and scrapie. Nature 215: 1043-1044.
121. Prusiner SB. 1982. Identification of a protein that purifies with the scrapie prion. Science 216: 136.
122. Come JH, Fraser PE, Lansbury PT Jr. 1993. A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc Natl Acad Sci USA 90: 5959-5963.
123. Jarrett JT, Lansbury PT Jr. 1993. Seeding " one-dimensional crystallization " of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
124. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehl JJ, Serpell L, Arnsdorf MF, Lindquist SL. 2000. Nucleation conformational conversion and the replication of conformational information by a prion determinant. Science 289: 1317-1321.
125. Pawar AP, DuBay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM. 2005. Prediction of aggregation-prone and aggregation-susceptible regions in proteins in neurodegenerative diseases. J Mol Biol 350: 379-392.
126. Armen RS, Alonso DO, Daggett V. 2004. Anatomy of an amyloidogenic intermediate: Conversion of beta-sheet to alpha-sheet structure in transthyretin at acidic pH. Structure 12: 1847-1863.
127. Lindberg MO, Oliveberg M. 2007. Malleability of protein folding pathways: A simple reason for complex behaviour. Curr Opin Struct Biol 17: 21-29.
128. Karplus M, Weaver DL. 1994. Folding dynamics: The diffusion-collision model and experimental data. Protein Sci 3: 650-668.
129. Beck C, Siemens X, Weaver DL. 2001. Diffusion-collision model study of misfolding in a four-helix bundle protein. Biophys J 81 (6): 3105-3115.
130. Liu D, Ren D, Huang H, Dankberg J, Rosenfield R, Cocco MJ, Li L, Brems DN, Remmele RL Jr. 2008. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry 47: 5088-5100.
131. Schlunegger MP, Bennett MJ, Eisenberg D. 1997. Oligomer formation by 3D domain swapping: A model for protein assembly and misassembly. Adv Protein Chem 50: 61-122.
132. Guo Z, Eisenberg D. 2006. Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Proc Natl Acad Sci USA 103: 8042-8047.
133. Nilsson M, Wang X, Rodziewicz-Motowidlo S, Jankowski R, Lindstrom V, Onnerfjord P, Westermark G, Grzonka Z, Jaskolski M, Grubb A. 2004. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C. J Biol Chem 279: 24236-24245.
134. Wahlbom M, Lindstrom V, Carlemalm E, Jaskolski M, Grubb A. 2007. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 282: 18318-18326.
135. Udgaonkar JB. 2008. Multiple routes and structure heterogeneity in protein folding. Annu Rev Biophys 37: 489-510.
136. Sali A, Shakhnovich E, Karplus M. 1994. How does a protein fold? Nature 369: 248-251.
137. Bogatyreva NS, Finkelstein AV. 2001. Cunning simplicity of protein folding landscapes. Protein Eng 14 (8): 521-523.
138. Privalov PL. 1979. Stability of proteins: Small globular proteins. Adv Protein Chem 33: 167-241.
139. Korzhnev DM, Lay LE. 2008. Probing invisible, low-population states of protein molecules by relaxation dispursion NMR spectroscopy: An application to protein folding. Acc. Chem Res 41 (3): 442-451.
140. Cellmer T, Bratko D, Prausnitz JM, Blanch H. 2007. Protein aggregation in silico. Trends Biotechnol 25 (6): 254-261.
141. Gsponer J, Vendruscolo M. 2006. Theoretical approaches to protein aggregation. Protein Pept Lett 13: 287-293.
142. Chan HS, Dill KA. 1998. Protein folding in the landscape perspective-Chevron plots and non-Arrhenius kinetics. Proteins 30: 2-33.
143. Dill KA, Bromberg S, Yue K, Fiebig KM, Yee DP, Thomas PD, Chan HS. 1995. Principles of protein folding - A perspective from simple exact models. Protein Sci 4 (4): 561-602.
144. Miyazawa S, Jernigan RL. 1985. Estimation of effective interresidue contact energies from protein crystal structures: Quasi-chemical approximation. Macromolecules 18 (3): 534-552.
145. Cellmer T, Bratko D, Prausnitz JM, Blanch H. 2005. Thermodynamics of folding and association of lattice-model proteins. J Chem Phys 122 (174908): 1-10.
146. Chan T, Jankovic B, Le V, Naverniouk I. 2004. Comparative Study of Hydrophobic-Polar and Miyazawa-Jernigan Energy Functions in Protein Folding on a Cubic Lattice using Pruned-Enriched Rosenbluth Monte Carlo Algorithm. Available at http://www.cs.ubc.ca/labs/beta/Div/CPSC545-WS-04/JanEtAl.pdf.
147. Nguyen HD, Hall CK. 2004. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101(46): 16180-16185.
148. Ma B, Nussinov R. 2002. Stabilities and conformations of Alzheimer's ß-amyloid peptide oligomers (A ß 16-22, A ß 16-35 and A ß 10-35): Sequence effects. Proc Natl Acad Sci USA 99 (22): 14126-14131.
149. Pande VS, Rokhsar DS. 1999. Folding pathway of a lattice model for proteins. Proc Natl Acad Sci USA 96: 1273-1278.
150. Sutto L, Tiana G, Broglia RA. 2006. Heirarchy of events in protein folding: Beyond the Go model. Protein Sci 15: 1638-1652.
151. Maity H, Maity M, Krishna MM, Mayne L, Englander SW. 2005. Protein folding: The stepwise assembly of foldon units. Proc Natl Acad Sci USA 102: 4741-4746.
152. Tozzini V. 2005. Coarse-grained models for proteins. Curr Opin Struct Biol 15: 144-150.
153. Clementi C. 2008. Coarse-grained models of protein folding: Toy models or predictive tools? Curr Opin Struct Biol 18: 10-15.
154. Zhou Y, Karplus M. 1999. Folding of a model three-helix bundle protein: A thermodynamic and kinetic analysis. J Mol Biol 293: 917-951.
155. Zacharias M. 2003. Protein docking with a reduced protein model accounting for side-chain flexibility. Protein Sci 12: 1271-1282.
156. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, Buldyrev SV, Stanley HE, Dokholyan NV. 2004. Molecular dynamics simulation of amyloid ß dimer formation. Biophys J 87: 2310-2321.
157. Levy Y, Jortner J, Becker OM. 1998. Solvent effects on the energy landscapes and folding kinetics of polyalanine. Proc Natl Acad Sci USA 98 (5): 2188-2193.
158. Nguyen HD, Hall CK. 2004. Phase diagrams describing fibrillization by polylanine peptides. Biophys J 87: 4122-4134.
159. Pellarin R, Caflisch A. 2006. Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol 360: 882-892.
160. Hummer G, Grarde S, Garcia AE, Pohorille A, Pratt LR. 1996. An information theory model of hydrophobic interactions. Proc Natl Acad Sci USA 93: 8951-8955.
161. Kumar S, Yin X, Trapp BD, Hoh JH, Paulaitis ME. 2002. Relating interactions between neurofilametns to the structure of axonal neurofilament distributions through polymer brush models. Biophys J 82 (5): 2360-2372.
162. Steward RE, Thornton JM. 2002. Prediction of strand pairing in antiparallel and parallel beta-sheets using information theory. Proteins 48 (2): 178-191.
163. Naderi-Manesh H, Sadeghi M, Arab S, Moosavi Movahedi AA. 2001. Prediction of protein surface accessibilty with information theory. Proteins 42 (4): 452-459.
164. Ofran Y, Rost B. 2003. Analysing six types of protein-protein interfaces. J Mol Biol 325 (2): 377-387.
165. Bogan AA, Thorn KS. 1998. Anatomy of hot spots in protein interfaces. J Mol Biol 280: 1-9.
166. Chakrabarti P, Janin J. 2002. Dissecting protein: Protein recognition sites. Proteins Struct Funct Genet 47: 334-343.
167. Mintseris J, Weng Z. 2004. Optimizing protein representations with information theory. Genome Inform 15 (1): 160-169.
168. Aswad DW. 1995. Deamidation and Isoaspartate Formation in Peptides and Proteins. Boca Raton, FL: CRC Press.
169. Zbilut JP, Colosimo A, Conti F, Colafranceschi M, Manetti C, Valerio MC, Webber CLJ, Giuliani A. 2003. Protein aggregation/folding: The role of deterministic singularities of sequence hydrophobicity as determined by nonlinear signal analysis of acylphosphatase and A ß (1-40). Biophys J 85: 3544-3557.
170. Weisel JW, Veklich Y, Gorkun O. 1993. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 232: 285.
171. Shirley BA. 1995. Protein Stability and Folding: Theory and Practice. Totowa, NJ: Humana Press.
172. Perutz MF. 1996. Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects. Curr Opin Struct Biol 6: 848-858.
173. Bevivino AE, Loll PJ. 2001. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel ß-fibrils. Proc Natl Acad Sci USA 98 (21): 11955-11960.
174. Ross CA, Poirier MA, Wanker EE, Amzel M. 2003. Polyglutamine fibrillogenesis: The pathway unfolds. Proc Natl Acad Sci USA 100 (1): 1-3.
175. Triguero L, Singh R, Prabhakar R. 2008. Comparative moelcular dynamics studies of wild-type and oxidized forms of full-length Alzheimer amyloid ß-peptides A ß (1-40) and A ß (1-42). J Phys Chem B 112: 7123-7131.
176. Watson AA, Fairlie DP, Craik DJ. 1998. Solution structure of methionine-oxidized amyloid ß-peptide (1-40). Does oxidation affect conformational switching? Biochemistry 37: 12700.
177. Yan Y, McCallum SA, Wang C. 2008. M35 oxidation induces A ß-like structural and dynamical changes in A ß 42. J Am Chem Soc 130: 5394-5395.
178. Breydo L, Bocharova OV, Makarava N, Salnikov VV, Anderson M, Baskakov IV. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 44: 15534-15543.
179. Soenderkaer S, Carpenter JF, von de Weert M, Hansen LL, Flink J, Frokjaer S. Effects of sucrose on rFVIIa aggregation and methionine oxidation. Eur J Pharm Sci 21 (5): 597-606.
180. Ruiz L, Aroche K, Reyes N. 2006. Aggregation of recombinant human interferon alpha 2b in solution: Technical note. AAPS Pharm Sci Tech 7(4): E1-E5.
181. Ding F, Dokholyan NV. 2008. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proc Natl Acad Sci USA 105 (50): 19696-19701.
182. Schafer FQ, Buettner GR. 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Rad Biol Med 30: 1191-1212.
183. den Hertog J, Groen A, van der Wijk T. 2005. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434: 11-15.
184. Chiarugi P, Buricchi F. 2007. Protein tyrosin phosphorylation and reversible oxidation: Two cross-talking posttranslation modifications. Antioxid Redox Signal 9: 1-24.
185. Ruf RAS, Lutz EA, Zigoneanu IG, Pielak GJ. 2008. a-Synuclein conformation affects its tyrosine-dependent oxidative aggregation. Biochemistry 47: 13604-13609
186. Norris EH, Giasson BI, Ischiropoulos H, Lee VM. 2003. Effects of oxidative and nitrative challeneges on R-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem 278: 27230-27240.
187. Siebold B, Qin R, Glanville RW, Hofmann H, Deutzmann R, Kuhn K. 1987. Construction of a model for the aggregation and cross-linking region (7S domain) of type IV collagen based upon an evaluation of the primary structure of the a1 and a2 chains in this region. Eur J Biochem 168: 569-575.
188. Bailey AJ, Sims TJ, Avery NC, Miles CA. 1993. Chemistry of collagen cross-links: Glucose-mediated covalent cross-linking of type-IV collagen in lens capsules. Biochem J 296: 489-496.
189. Nilsson MR, Driscoll M, Raleigh DP. 2002. Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: Implications for the study of amyloid formation. Protein Sci 11: 342-349.
190. Flaugh S, Mills IA, King J. 2006. Glutamine deamidation destabiliizes human ? D-crystallin and lowers the kinetic barrier to unfolding. J Biol Chem 281: 30782-30793
191. Yamaguchi S, Jeenes DJ, Archer DB. 2001. Protein-glutaminase from Chryseobacterium proteolyticum, an enzyme that deamidates glutaminyl residues in proteins: Purification, characterization and gene cloning. Eur J Biochem 268 (5): 1410-1421.
192. Yong YH, Yamaguchi S, Gu YS, Mori T, Matsumura Y. 2004. Effects of enzymatic deamidation by protein-glutaminase on structure and functional properties of a-zein. J Agric Food Chem 52 (23): 7094-7100.
193. Calabrese MF, Eakin CM, Wang JM, Miranker AD. 2008. A regulatable switch mediates self-association in an immunoglobulin fold. Nat Struct Mol Biol 15 (9): 965-971.
194. Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Muller SA, Kistler J, Cooper GJS, Aebi U. 2000. Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol 130: 352-362.
195. Wang Q, Johnson JL, Agar NYR, Agar JN. 2008. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6 (7): 1508-1526.
196. Tartaglia GG, Vendruscolo M. 2008. The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev 37: 1395-1401.
197. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J Mol Biol 380: 425-436.
198. Tartaglia GG, Cavalli A, Pellarin R, Caflisch A. 2005. Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci 14: 2723-2734.
199. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. 2004. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22 (10): 1302-1306.
200. Tessier PM, Lindquist S. 2007. Prion recognition elements govern nucleation, strain specificity and species barrier. Nature 447: 556-561.
201. Bui JM, Cavalli A, Gsponer J. 2008. Identification of aggregation-prone elements by using interaction-energy matrices. Angew Chem Int Ed 47: 7267-7269.
202. Trovato A, Seno F, Tossato SCE. 2007. The PASTA server for protein aggregation prediction. Prot Eng Des Sel 20: 521-523.
203. Conchillo-Sole O, de Groot NS, Aviles FX, Vendrell J, Daura X, Ventura S. 2007. AGGRESCAN: A server for the prediction and evaluation of hot spots of aggregation in polypeptides. BMC Bioinformatics 8: 65.
204. Ventura S. 2005. Sequence determinants of protein aggregation: Tools to increase protein solubility. Microb Cell Fact 4: 11-19.
205. Sharma S, Ding F, Nie H, Watson D, Unnithan A, Lopp J, Pozefsky D, Dokholyan NV. 2006. iFold: A platform for ineteractive folding simulations of proteins. Bioinformatics 22 (21): 2693-2694.
206. Ding F, Prutzman KC, Campbell SL, Dokholyan NV. 2006. Topological determinants of protein domain swapping. Structure 14: 5-14.
207. Iakoucheva LM, Dunker AK. 2003. Order, disorder, and flexibility: Prediction from protein sequence. Structure 11 (11): 1316-1317.
208. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. 2003. Protein disorder prediction: Implications for structural proteomics. Structure 11(11): 1316-1317.